IO Biotech’s vaccines activate T cells to modify the tumor microenvironment, targeting both cancer and immune-suppressive cells
From “Super Skeptical” Beginnings, a New Immune-Modulatory Vaccine Awaits Phase 3 Results Data exploring a new type of tumor-fighting vaccine,...